Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 3, 2007, Pages 269-273

  Kalogeromitros, Demetrios ^a   Syrigou, E Katerini I ^a   Makris, Michael ^a   Kempuraj, Duraisamy ^b   Stavrianeas, Nikolaos G ^a   Vasiadi, Magdalini ^b   Theoharides, Theoharis C ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; POLLEN ANTIGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PARIETARIA; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 33947244925     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60717-X     Document Type: Article

References (33)

1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108:S2-S8.
2. Leger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med. 2006;166:1744-1748.
3. Klein GL, Ziering RW, Girsh LS, Miller MF. The allergic irritability syndrome: four case reports and a position statement from the Neuroallergy Committee of the American College of Allergy. Ann Allergy. 1985;55:22-24.
4. Hashizume H, Takigawa M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2006;6:335-339.
5. Annesi-Maesano I, Beyer A, Marmouz F, Mathelier-Fusade P, Vervloet D, Bauchau V. Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? results of a large-scale cross-sectional study in a French population. Br J Dematol. 2006;154:1128-1136.
6. Chen E, Fisher EB, Bacharier LB, Strunk RC. Socioeconomic status, stress, and immune markers in adolescents with asthma. Psychosom Med. 2003;65:984-992.
7. Pawankar R. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy. 2005;87:111-129.
8. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749-786.
9. Vliagoftis H, Befus AD. Mast cells at mucosal frontiers. Curr Mol Med. 2005;5:573-589.
10. Williams RM, Bienenstock J, Stead RH. Mast cells: the neuroimmune connection. Chem Immunol. 1995;61:208-235.
11. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 2004;146:1-12.
12. Kempuraj D, Papadopoulou NG, Lytinas M, et al. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology. 2004;145:43-48.
13. Bugajski AJ, Koprowska B, Thor P, Glod R, Bugajski J. Involvement of nitric oxide in central histaminergic stimulation of the hypothalamic-pituitary- adrenal axis. J Physiol Pharmacol. 2000;51:907-915.
14. Tsagarakis S, Gillies G, Rees LH, Besser M, Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology. 1989;49:98-101.
15. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 1993;77:1690-1694.
16. Caldwell JE, Heiss SG, Mermall V, Cooper JA. Effects of CapZ, an actin capping protein of muscle, on the polymerization of actin. Biochemistry. 1989;28:8506-8514.
17. Bugajski AJ, Gadek-Michalska A, Bugajski J. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamic- pituitary-adrenal response during crowding stress. J Physiol Pharmacol. 2006;57:463-477.
18. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983;128:597-602.
19. Schleimer RP. Interactions between the hypothalamic-pituitary-adrenal axis and allergic inflammation. J Allergy Clin Immunol. 2000;106:S270-S274.
20. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 1999;79:1-71.
21. Kandere-Grzybowska K, Letourneau R, Boucher W, et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol. 2003;171:4830-4836.
22. Karalis K, Louis JM, Bae D, Hilderbrand H, Majzoub JA. CRH and the immune system. J Neuroimmunol. 1997;72:131-136.
23. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci. 2004;25: 563-568.
24. Theoharides TC, Douglas WW. Somatostatin induces histamine secretion from rat peritoneal mast cells. Endocrinology. 1978; 102:1637-1640.
25. Theoharides TC. Mast cells: the immune gate to the brain. Life Sci. 1990;46:607-617.
26. Esposito P, Gheorghe D, Kandere K, et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 2001;888:117-127.
27. Cao J, Papadopoulou N, Kempuraj D, et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol. 2005;174:7665-7675.
28. Gadek-Michalska A, Chlap Z, Turon M, Bugajski J, Fogel WA. The intracerebroventricularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats. Agents Actions. 1991;32:203-208.
29. Bugajski AJ, Chlap Z, Gadek-Michalska A, Borycz J, Bugajski J. Degranulation and decrease in histamine levels of thalamic mast cells coincides with corticosterone secretion induced by compound 48/80. Inflamm Res. 1995;44(suppl 1):S50-S51.
30. Matsumoto I, Inoue Y, Shimada T, Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J Exp Med. 2001;194:71-78.
31. Stenzel-Poore M, Vale WW, Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 1993;132:1313-1318.
32. Foldes A, Nemethy Z, Szalay O, Kovacs KJ. Anaphylactoid reactions activate hypothalamo-pituitary-adrenocortical axis: comparison with endotoxic reactions. Brain Res Bull. 2000;52: 573-579.
33. Gurish MF, Austen KF. The diverse roles of mast cells. J Exp Med. 2001;194:1-6.